GO:1900208 regulation of cardiolipin metabolic process: Mitochondrial Lipid Homeostasis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900208 describes any process that modulates the frequency, rate or extent of cardiolipin metabolic process, the central mitochondrial phospholipid pathway.
• Cardiolipin is a signature mitochondrial phospholipid required for cristae architecture, respiratory chain supercomplex stability and mitochondrial bioenergetics.
• Regulation of cardiolipin metabolism controls ferroptosis, inflammatory metabolic reprogramming and cell death signaling.
• Key regulators include Gpx4, GRB2, and the cardiolipin biosynthetic enzymes of the CDP-diacylglycerol pathway.
• Cardiolipin dysregulation is linked to acute renal failure, Parkinson's disease, neurodegeneration and metabolic inflammation.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect causal roles of cardiolipin regulators.
Description
GO:1900208, regulation of cardiolipin metabolic process, is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of cardiolipin metabolic process. Cardiolipin (diphosphatidylglycerol) is a unique dimeric phospholipid found almost exclusively in the inner mitochondrial membrane, where it is required for the activity of several mitochondrial enzymes and for the structural integrity of the respiratory chain. Because cardiolipin metabolism sits at the intersection of mitochondrial bioenergetics, membrane dynamics and cell death, its regulation is a major research focus. The term encompasses both the biosynthetic arm, which in mammals proceeds through the CDP-diacylglycerol pathway and subsequent remodeling steps, and the degradative/remodeling arm that adjusts acyl chain composition and total cardiolipin content. Classical work established that cardiac cardiolipin biosynthesis is subject to developmental and hormonal regulation, providing an early framework for the concept of regulated cardiolipin metabolism. More recent studies have shown that cardiolipin levels and species composition are actively controlled during inflammatory metabolic reprogramming and in response to cell death signals. For researchers, GO:1900208 provides a formal annotation framework to connect genes, regulatory inputs and phenotypic outcomes. Loss of the ferroptosis regulator Gpx4 causes acute renal failure in mice and is associated with altered lipid peroxidation of mitochondrial membranes, underscoring how cardiolipin regulation intersects with redox biology. In the brain, cardiolipin content is modulated by sex and gonadal hormones, indicating that regulation of cardiolipin metabolic process is physiologically tunable across tissues. This article synthesizes the definition, mechanisms, key genes, disease links and experimental strategies relevant to GO:1900208.
regulation of cardiolipin metabolic process At A Glance
| GO ID | GO:1900208 |
|---|---|
| GO term | regulation of cardiolipin metabolic process |
| Ontology | biological_process |
| Synonym | regulation of cardiolipin metabolism; regulation of diphosphatidylglycerol metabolic process; regulation of diphosphatidylglycerol metabolism |
| Major function | Modulates the frequency, rate or extent of cardiolipin metabolic process, thereby controlling mitochondrial membrane phospholipid homeostasis |
| Biological context | Inner mitochondrial membrane biogenesis, respiratory chain supercomplex assembly, cristae morphology |
| Disease relevance | Ferroptosis-associated acute renal failure, Parkinson's disease, inflammatory metabolic reprogramming, neurodegeneration |
| Key regulators | Gpx4, GRB2, cardiolipin biosynthetic enzymes, hormonal and sex-dependent inputs |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, lipidomics, Seahorse respirometry, fluorescence imaging |
What Is GO:1900208?
In our own words, GO:1900208 (regulation of cardiolipin metabolic process) refers to any biological process that changes the rate, frequency or extent of cardiolipin metabolism. It does not describe the metabolic reactions themselves, but the upstream or feedback controls that set how much cardiolipin is made, remodeled or turned over. The term is synonymous with regulation of cardiolipin metabolism and regulation of diphosphatidylglycerol metabolic process, reflecting the alternative chemical name for cardiolipin.
Why Is regulation of cardiolipin metabolic process Important in Cell Biology?
Regulation of cardiolipin metabolic process is important because cardiolipin is not merely a structural lipid; it directly supports mitochondrial energy transduction, organizes respiratory supercomplexes and participates in apoptotic and ferroptotic signaling. When this regulation fails, mitochondria lose efficiency and integrity, contributing to organ injury such as acute renal failure and to chronic neurodegenerative conditions such as Parkinson's disease. Understanding GO:1900208 therefore informs mitochondrial biology, cell death research and therapeutic development.
• Cardiolipin is required for optimal activity of respiratory chain complexes and for supercomplex stability.
• Regulation of cardiolipin metabolism controls susceptibility to ferroptosis, a non-apoptotic iron-dependent cell death.
• Cardiolipin coordinates inflammatory metabolic reprogramming through Complex II disassembly and degradation.
• Loss of Gpx4, a ferroptosis regulator, triggers acute renal failure in mice, linking cardiolipin redox biology to organ injury.
• Ginsenoside Rg3 restores mitochondrial cardiolipin homeostasis via GRB2, highlighting druggable regulation in Parkinson's disease models.
• Cardiolipin regulates bacterial two-component systems, showing the term's relevance beyond eukaryotes.
• Mammalian cardiolipin biosynthesis is developmentally and hormonally regulated, as shown in heart and brain.
• Sex differences and gonadal hormones modulate brain cardiolipin, indicating physiological tunability of GO:1900208.
• Cardiolipin is implicated in the regulation of multiple cell death modalities, expanding its disease relevance.
• CRISPR-based models enable causal testing of candidate regulators within this GO term.
What Happens During regulation of cardiolipin metabolic process?
Biosynthetic control of cardiolipin
In simple terms: Cells decide how much cardiolipin to make by controlling the enzymes of its biosynthesis.
In mammals, cardiolipin biosynthesis proceeds through the CDP-diacylglycerol pathway, in which phosphatidic acid is converted to CDP-diacylglycerol and then to phosphatidylglycerol phosphate, phosphatidylglycerol, and finally cardiolipin. Regulation of this arm adjusts the rate of cardiolipin production in response to developmental, hormonal and metabolic cues, as demonstrated in cardiac tissue where cardiolipin biosynthesis is under regulatory control. This biosynthetic control is a core component of GO:1900208 because it sets the upper limit of cardiolipin available for mitochondrial membrane assembly.
Remodeling and acyl chain maturation
In simple terms: After cardiolipin is made, its fatty acid chains are reshaped to fit the needs of the mitochondrion.
Nascent cardiolipin undergoes remodeling to achieve the species composition typical of mature mitochondria, a step that is essential for respiratory chain function. This remodeling is part of cardiolipin metabolic process and is subject to regulation, thereby falling under GO:1900208. Perturbations in remodeling alter supercomplex stability and mitochondrial bioenergetics, which has been observed in the context of inflammatory metabolic reprogramming where cardiolipin coordinates Complex II disassembly and degradation.
Redox-linked regulation and ferroptosis
In simple terms: Oxidative stress can damage cardiolipin, and cells have regulators that either protect or promote this damage.
Gpx4 is a glutathione peroxidase that protects membranes from lipid peroxidation; its inactivation triggers acute renal failure in mice and is linked to ferroptosis, a cell death modality dependent on mitochondrial lipid oxidation. Cardiolipin is a major target of peroxidation in this context, so regulation of cardiolipin metabolic process is functionally coupled to redox control and cell death execution. This redox-linked regulation is a key node within GO:1900208 because it determines whether cardiolipin remains functional or becomes a death signal.
Hormonal and sex-dependent regulation
In simple terms: Hormones and biological sex can change how much cardiolipin is present in tissues such as the brain.
Brain cardiolipin content differs between sexes and is regulated by gonadal hormones, demonstrating that regulation of cardiolipin metabolic process is subject to endocrine inputs. This physiological regulation is relevant to neurodegenerative disease because mitochondrial lipid composition influences neuronal resilience. Thus GO:1900208 includes hormonal modulation of cardiolipin metabolism as a distinct regulatory layer.
Pharmacological and signaling modulation
In simple terms: Drugs and signaling proteins can turn cardiolipin metabolism up or down.
Ginsenoside Rg3 restores mitochondrial cardiolipin homeostasis via GRB2, providing evidence that pharmacological agents can modulate this process in Parkinson's disease models. In bacteria, cardiolipin regulates two-component systems, indicating that regulation of cardiolipin metabolism also feeds back into signal transduction. These examples show that GO:1900208 encompasses both endogenous signaling and exogenous pharmacological control of cardiolipin metabolism.
Key Genes Involved in GO:1900208 regulation of cardiolipin metabolic process
The following genes and proteins have been experimentally linked to regulation of cardiolipin metabolic process or to its downstream mitochondrial consequences.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Gpx4 | Glutathione peroxidase protecting membranes from lipid peroxidation; loss triggers ferroptosis and acute renal failure | Key regulator linking cardiolipin redox biology to cell death and organ injury |
| GRB2 | Adaptor protein mediating signaling that restores mitochondrial cardiolipin homeostasis | Target of ginsenoside Rg3 in Parkinson's disease models |
| CDS1/CDS2 | CDP-diacylglycerol synthases in the cardiolipin biosynthetic pathway | Biosynthetic control node within GO:1900208 |
| PGS1 | Phosphatidylglycerol phosphate synthase in cardiolipin biosynthesis | Enzyme controlling cardiolipin precursor supply |
| PTPMT1 | Phosphatidylglycerol phosphate phosphatase in cardiolipin biosynthesis | Regulatory step in mammalian cardiolipin biosynthesis |
| CRLS1 | Cardiolipin synthase catalyzing the final step of cardiolipin biosynthesis | Core enzyme of cardiolipin metabolic process |
| TAZ | Tafazzin, a transacylase involved in cardiolipin remodeling | Remodeling regulator relevant to mitochondrial membrane composition |
| ALCAT1 | Acyltransferase implicated in cardiolipin remodeling and mitochondrial dysfunction | Remodeling enzyme with disease relevance |
| PLA2G6 | Phospholipase A2 family member implicated in cardiolipin turnover | Links cardiolipin metabolism to cell death regulation |
| SDHA/SDHB | Complex II subunits whose disassembly is coordinated by cardiolipin | Readout of cardiolipin-dependent respiratory chain regulation |
| NDUFS1 | Complex I subunit dependent on cardiolipin for activity | Bioenergetic readout of cardiolipin regulation |
| COX4I1 | Complex IV subunit requiring cardiolipin for function | Mitochondrial respiration readout |
| ATP5F1A | ATP synthase subunit whose activity depends on cardiolipin | Bioenergetic readout of cardiolipin regulation |
| VDAC1 | Outer membrane channel influenced by mitochondrial lipid environment | Context for cardiolipin-dependent mitochondrial signaling |
| Bax/Bak | Apoptotic effectors whose activation involves cardiolipin | Links GO:1900208 to apoptosis |
| Caspase-8 | Initiator caspase in death receptor signaling influenced by mitochondrial lipids | Cell death context for cardiolipin regulation |
| GPX4 (human) | Human ortholog of Gpx4 with conserved ferroptosis-protective function | Translational relevance for human disease models |
How Is regulation of cardiolipin metabolic process Regulated?
Regulation of cardiolipin metabolic process is itself regulated at multiple levels. Biosynthetic enzymes of the CDP-diacylglycerol pathway set the rate of cardiolipin production, and this biosynthetic flux is responsive to developmental and hormonal signals in the heart. In the brain, gonadal hormones and sex influence cardiolipin content, showing endocrine control of this process. Redox status provides another layer: Gpx4 activity determines whether cardiolipin undergoes protective turnover or peroxidative damage, and loss of Gpx4 triggers ferroptosis and acute renal failure in mice. Signaling adaptors such as GRB2 mediate pharmacological restoration of cardiolipin homeostasis, indicating that receptor-proximal signaling can modulate this process. Finally, cardiolipin itself regulates bacterial two-component systems, revealing feedback regulation between cardiolipin metabolism and signal transduction.
regulation of cardiolipin metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Gpx4 | Ferroptosis-associated acute renal failure | Conditional knockout mouse; renal tubular cell KO |
| GRB2 | Parkinson's disease; cardiolipin homeostasis | Neuronal overexpression or knockdown; Rg3 treatment model |
| CRLS1 | Mitochondrial dysfunction via impaired cardiolipin synthesis | CRISPR knockout in cultured cells with lipidomics readout |
| TAZ | Cardiolipin remodeling defects and mitochondrial membrane abnormalities | Knockout or point-mutation models with respirometry |
| SDHA/SDHB | Inflammatory metabolic reprogramming via Complex II disassembly | Knockout or tagged knock-in for Complex II stability assays |
Acute kidney injury and ferroptosis
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice, and this phenotype is tied to lipid peroxidation of mitochondrial membranes including cardiolipin. Because cardiolipin is a principal mitochondrial phospholipid, dysregulation of GO:1900208 can sensitize renal tubular cells to ferroptotic death. This makes regulation of cardiolipin metabolic process a candidate pathway for therapeutic intervention in acute kidney injury.
Parkinson's disease and neurodegeneration
Ginsenoside Rg3 restores mitochondrial cardiolipin homeostasis via GRB2 to prevent Parkinson's disease in experimental models, directly linking GO:1900208 to neurodegeneration. Brain cardiolipin is also regulated by sex and gonadal hormones, which may contribute to sex differences in neurodegenerative disease susceptibility. Cardiolipin-dependent cell death mechanisms further support a role for this process in neuronal loss.
Inflammatory metabolic reprogramming
Cardiolipin coordinates inflammatory metabolic reprogramming through regulation of Complex II disassembly and degradation, connecting GO:1900208 to immune-metabolic phenotypes. This suggests that regulators of cardiolipin metabolism may influence inflammatory disease states and mitochondrial remodeling in activated immune cells.
Mitochondrial dysfunction and cell death
Cardiolipin is involved in the regulation of multiple cell death modalities, including apoptosis and ferroptosis, so perturbations in GO:1900208 can shift cell fate decisions. Because cardiolipin supports respiratory chain complexes, its dysregulation impairs bioenergetics and can amplify mitochondrial dysfunction in disease.
From regulation of cardiolipin metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for cardiolipin biosynthesis? | CRISPR knockout cell line plus lipidomics |
| Does a specific residue control cardiolipin remodeling? | Point-mutation knock-in of the catalytic residue |
| Does a disease variant alter cardiolipin regulation? | Knock-in of the patient variant with mitochondrial phenotyping |
| Where does a regulator localize within mitochondria? | Endogenous tagged knock-in with fluorescence imaging |
| Does overexpression of a regulator protect from ferroptosis? | Doxycycline-inducible overexpression in renal or neuronal cells |
| Does loss of a regulator alter respiratory supercomplexes? | Knockout with blue-native PAGE and respirometry |
How to Study the regulation of cardiolipin metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | Cardiolipin species and total content | Validation of CRISPR KO or overexpression effects |
| Seahorse respirometry | Mitochondrial oxygen consumption rates | Functional readout of cardiolipin regulation |
| Blue-native PAGE | Respiratory supercomplex assembly | Assessing Complex II disassembly and stability |
| Lipid peroxidation reporters | Oxidative damage to mitochondrial lipids | Ferroptosis sensitivity testing |
| Fluorescence imaging | Subcellular localization and morphology | Tagged knock-in and mitochondrial network analysis |
| Western blot | Protein levels of cardiolipin regulators | Confirmation of KO, knockdown or overexpression |
| qPCR / RNA-seq | Transcript levels of biosynthetic enzymes | Pathway-level response profiling |
| CRISPR library screening | Candidate regulators of cardiolipin metabolism | Unbiased discovery of GO:1900208 modulators |
Lipidomics and cardiolipin quantification
Mass spectrometry-based lipidomics is the primary method to measure cardiolipin species and total content, allowing researchers to determine whether a genetic perturbation changes regulation of cardiolipin metabolic process. This approach is essential for validating CRISPR models targeting biosynthetic or remodeling enzymes.
Mitochondrial respirometry and supercomplex analysis
Seahorse respirometry and blue-native PAGE measure the functional consequences of altered cardiolipin regulation, including respiratory chain activity and supercomplex stability. These assays connect GO:1900208 to mitochondrial bioenergetics and are commonly used after knockout or overexpression of candidate regulators.
Cell death and ferroptosis assays
Ferroptosis is assessed with lipid peroxidation reporters, viability assays and rescue by ferroptosis inhibitors, as demonstrated in Gpx4 loss-of-function studies. Such assays link regulation of cardiolipin metabolic process to cell death outcomes.
Imaging and subcellular localization
Fluorescence imaging of mitochondria-targeted reporters and tagged proteins reveals how regulators localize and whether cardiolipin distribution changes under perturbation. Imaging complements biochemical lipidomics by providing spatial context for GO:1900208.
How CRISPR Can Be Used to Study GO:1900208 regulation of cardiolipin metabolic process
Knockout
CRISPR knockout of candidate genes such as CRLS1, TAZ or Gpx4 allows direct testing of whether a gene is required for regulation of cardiolipin metabolic process. Knockout clones can be profiled by lipidomics and respirometry to quantify cardiolipin loss and mitochondrial dysfunction.
Point Mutation
Point-mutation models introduce specific amino acid substitutions to test catalytic or regulatory residues in cardiolipin enzymes and regulators. Such models distinguish loss of enzymatic activity from loss of protein scaffolding function within GO:1900208.
Knock-in
Knock-in of disease-associated variants or epitope tags enables precise interrogation of cardiolipin regulators in a native genomic context. Tagged knock-in lines support localization and interaction studies relevant to regulation of cardiolipin metabolic process.
Overexpression
Overexpression models test whether increased dosage of a regulator such as GRB2 or Gpx4 protects mitochondria and cells from cardiolipin-dependent stress. Inducible overexpression is particularly useful for rescue experiments in ferroptosis and neurodegeneration models.
How EDITGENE Supports regulation of cardiolipin metabolic process Research
Researchers studying regulation of cardiolipin metabolic process-related genes often need to determine whether a candidate gene is causally involved in cardiolipin homeostasis, mitochondrial function or cell death. EDITGENE provides publication-ready CRISPR cell models and screening services that let you move from candidate gene to mechanistic evidence with confidence.
Contact EDITGENE today to design your custom CRISPR model for regulation of cardiolipin metabolic process research.
Frequently Asked Questions About regulation of cardiolipin metabolic process
What is GO:1900208 regulation of cardiolipin metabolic process?
GO:1900208 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of cardiolipin metabolic process, where cardiolipin is a mitochondrial phospholipid also known as diphosphatidylglycerol.
What genes are involved in regulation of cardiolipin metabolic process?
Key genes include Gpx4, GRB2, CRLS1, TAZ, PGS1, PTPMT1, CDS1/CDS2 and ALCAT1, all of which have been linked to cardiolipin biosynthesis, remodeling or redox protection.
Why is cardiolipin important for mitochondria?
Cardiolipin is required for respiratory chain complex activity, supercomplex stability and cristae architecture, making it essential for mitochondrial bioenergetics.
How is cardiolipin metabolism regulated?
It is regulated at the level of biosynthesis through the CDP-diacylglycerol pathway, by remodeling enzymes, by redox regulators such as Gpx4, and by hormonal and signaling inputs including GRB2.
What diseases are linked to cardiolipin dysregulation?
Cardiolipin dysregulation has been linked to ferroptosis-associated acute renal failure, Parkinson's disease, inflammatory metabolic reprogramming and mitochondrial dysfunction in neurodegeneration.
How can I study regulation of cardiolipin metabolic process in the lab?
Common approaches include CRISPR knockout or overexpression of candidate genes, lipidomics to quantify cardiolipin species, respirometry to measure mitochondrial function, and ferroptosis assays.
Does cardiolipin play a role in ferroptosis?
Yes, cardiolipin is a major mitochondrial lipid subject to peroxidation, and loss of the ferroptosis regulator Gpx4 triggers acute renal failure in mice, linking cardiolipin regulation to ferroptotic cell death.
Is cardiolipin regulation different between males and females?
Brain cardiolipin content differs by sex and is regulated by gonadal hormones, indicating sex-dependent regulation of cardiolipin metabolic process.
Can drugs modulate cardiolipin metabolism?
Ginsenoside Rg3 restores mitochondrial cardiolipin homeostasis via GRB2 in Parkinson's disease models, demonstrating pharmacological modulation of this process.
What CRISPR models are best for studying GO:1900208?
Knockout models test requirement, point-mutation models test specific residues, knock-in models test disease variants or tagging, and overexpression models test gain-of-function or rescue, depending on the research question.
Conclusion
GO:1900208 regulation of cardiolipin metabolic process captures a central control node in mitochondrial biology, linking phospholipid biosynthesis and remodeling to respiratory chain function, redox balance and cell death. Experimental evidence from Gpx4, GRB2 and biosynthetic enzyme studies shows that this regulation is both physiologically tunable and disease-relevant. For researchers, the term provides a precise annotation framework to connect genes, regulatory inputs and phenotypes. Combining CRISPR-based causal models with lipidomics, respirometry and cell death assays will continue to reveal how regulation of cardiolipin metabolic process can be targeted in acute organ injury, neurodegeneration and inflammatory disease.
References
- 1. Friedmann Angeli JP et al.. 2014. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice.. Nat Cell Biol 16(12):1180-91 PMID: 25402683
- 2. Reynolds MB et al.. 2023. Cardiolipin coordinates inflammatory metabolic reprogramming through regulation of Complex II disassembly and degradation.. Sci Adv 9(5):eade8701 PMID: 36735777
- 3. Qi LF et al.. 2024. Ginsenoside Rg3 Restores Mitochondrial Cardiolipin Homeostasis via GRB2 to Prevent Parkinson's Disease.. Adv Sci (Weinh) 11(39):e2403058 PMID: 39159293
- 4. Yeo WS et al.. 2023. Regulation of Bacterial Two-Component Systems by Cardiolipin.. Infect Immun 91(4):e0004623 PMID: 36975788
- 5. Mejia EM et al.. 2014. Mammalian cardiolipin biosynthesis.. Chem Phys Lipids 179:11-6 PMID: 24144810
- 6. Hatch GM. 1996. Regulation of cardiolipin biosynthesis in the heart.. Mol Cell Biochem 159(2):139-48 PMID: 8858564
- 7. Li ZZ et al.. 2025. The Mechanisms and Implications of Cardiolipin in the Regulation of Cell Death.. Cell Biochem Funct 43(3):e70066 PMID: 40103184
- 8. Acaz-Fonseca E et al.. 2020. Sex differences and gonadal hormone regulation of brain cardiolipin, a key mitochondrial phospholipid.. J Neuroendocrinol 32(1):e12774 PMID: 31323169
